Fluorescence imaging of antibiotic clofazimine encapsulated within mesoporous silica particle carriers: relevance to drug delivery and the effect on its release kinetics

2018 ◽  
Vol 20 (17) ◽  
pp. 11899-11911 ◽  
Author(s):  
Lorenzo Angiolini ◽  
Sabrina Valetti ◽  
Boiko Cohen ◽  
Adam Feiler ◽  
Abderrazzak Douhal

Time-resolved FLIM experiments show how hydrophobicity and hydrophilicity of mesoporous silica particles affect the distribution and release of the loaded antibiotic clofazimine.

2020 ◽  
Vol 7 (9) ◽  
pp. 2654-2668
Author(s):  
Wei Li ◽  
Xiao-shan Chu ◽  
Shu-ao He ◽  
Xue-chuan Wang ◽  
Chuan-yi Wang

Gourd-like hollow mesoporous silica particles with large surface area supporting the Ag/AgBr Schottky junction for a high-efficieny TTC mineralization.


Nanoscale ◽  
2015 ◽  
Vol 7 (34) ◽  
pp. 14434-14443 ◽  
Author(s):  
Hussein Shokry ◽  
Ulriika Vanamo ◽  
Oliver Wiltschka ◽  
Jenni Niinimäki ◽  
Martina Lerche ◽  
...  

Pharmaceutics ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 460
Author(s):  
Minja Mladenović ◽  
Ibrahim Morgan ◽  
Nebojša Ilić ◽  
Mohamad Saoud ◽  
Marija V. Pergal ◽  
...  

Ruthenium complexes are attracting interest in cancer treatment due to their potent cytotoxic activity. However, as their high toxicity may also affect healthy tissues, efficient and selective drug delivery systems to tumour tissues are needed. Our study focuses on the construction of such drug delivery systems for the delivery of cytotoxic Ru(II) complexes upon exposure to a weakly acidic environment of tumours. As nanocarriers, mesoporous silica nanoparticles (MSN) are utilized, whose surface is functionalized with two types of ligands, (2-thienylmethyl)hydrazine hydrochloride (H1) and (5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)hydrazine (H2), which were attached to MSN through a pH-responsive hydrazone linkage. Further coordination to ruthenium(II) center yielded two types of nanomaterials MSN-H1[Ru] and MSN-H2[Ru]. Spectrophotometric measurements of the drug release kinetics at different pH (5.0, 6.0 and 7.4) confirm the enhanced release of Ru(II) complexes at lower pH values, which is further supported by inductively coupled plasma optical emission spectrometry (ICP-OES) measurements. Furthermore, the cytotoxicity effect of the released metallotherapeutics is evaluated in vitro on metastatic B16F1 melanoma cells and enhanced cancer cell-killing efficacy is demonstrated upon exposure of the nanomaterials to weakly acidic conditions. The obtained results showcase the promising capabilities of the designed MSN nanocarriers for the pH-responsive delivery of metallotherapeutics and targeted treatment of cancer.


Author(s):  
Marzieh Heidari Nia ◽  
Roya Koshani ◽  
Jose G. Munguia-Lopez ◽  
Ali Reza Kiasat ◽  
Joseph M. Kinsella ◽  
...  

2019 ◽  
Vol 12 (4) ◽  
pp. 153
Author(s):  
Vivek Trivedi ◽  
Ruchir Bhomia ◽  
John C Mitchell

Solid core drug delivery systems (SCDDS) were prepared for the oral delivery of biomolecules using mesoporous silica as core, bovine haemoglobin (bHb) as model drug and supercritical fluid (SCF) processing as encapsulation technique. The use of organic solvents or harsh processing conditions in the development of drug delivery systems for biomolecules can be detrimental for the structural integrity of the molecule. Hence, the coating on protein-immobilised particles was performed via supercritical carbon dioxide (scCO2) processing at a temperature lower than the melting point of myristic acid (MA) to avoid any thermal degradation of bHb. The SCDDS were prepared by bHb immobilisation on mesoporous silica followed by myristic acid (MA) coating at 43 °C and 100 bar in scCO2. bHb-immobilised silica particles were also coated via solvent evaporation (SE) to compare the protein release with scCO2 processed formulations. In both cases, MA coating provided required enteric protection and restricted the bHb release for the first two hours in simulated gastric fluid (SGF). The protein release was immediate upon the change of media to simulated intestinal fluid (SIF), reaching 70% within three hours. The release from SCF processed samples was slower than SE formulations, indicating superior surface coverage of MA on particles in comparison to the SE method. Most importantly, the protein conformation remained unchanged after the release from SCDDS as confirmed by circular dichroism. This study clearly demonstrates that the approach involving protein immobilisation on silica and scCO2 assisted melt-coating method can protect biomolecules from gastric environment and provide the required release of a biologic in intestine without any untoward effects on protein conformation during processing or after release.


2015 ◽  
Vol 1112 ◽  
pp. 172-175 ◽  
Author(s):  
Erna Febriyanti ◽  
Rino R. Mukti ◽  
Veinardi Suendo ◽  
I. Nyoman Marsih ◽  
Sugeng Triwahyono ◽  
...  

In this research, several precursors were chosen to solve the drawbacks of using toxic and expensive chemicals in the synthesis of fibrous mesoporous silica particle via self-assembly process in microemulsion system. The synthesis of this emerging material normally is realized by using toxic cetylpyridinium bromide (CPB) as common structure directing agent in conjunction with combined cyclohexane and n-pentanol as expensive solvent and co-solvent, respectively. Less toxic cetyltrimethylammonium bromide (CTAB) can be the replacement for CPB but the use of this surfactant may drastically reduce the surface area of the resulting product. Herein, we report that the use of CTAB with combined toluene and n-butanol as affordable solvents can be used to synthesize fibrous mesoporous silica particle with high surface area. The material was well characterized by field emission scanning electron microscopy (FE-SEM), transmission electron microscopy (TEM), N2 adsorption/ desorption, X-ray difraction (XRD)and thermal gravimetry (TG). This material might be applied in potential applications such as catalysis, drug delivery and adsorption. Moreover, it can be used as a hard-template for fabricating another novel fibrous materials.


2012 ◽  
Vol 12 (8) ◽  
pp. 775-788 ◽  
Author(s):  
J. Pang ◽  
Y. Luan ◽  
X. Yang ◽  
Y. Jiang ◽  
L. Zhao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document